Despite the current global logistical gridlock, the pharmaceutical industry has generated significant revenues across various diagnostics, research, and healthcare segments over the past year. With the emergence of new COVID-19 variants causing an occasional surge of cases, and with a rise in chronic ailments worldwide, the pharma industry is projected to expand. Furthermore, the increasing medical needs of an aging population and consistent innovations from the sector should drive the industry’s long-term growth.
Increasing rates of pharma business collaborations, accurate digitized diagnoses, and an increasing volume of bio-medical trials are set to contribute to the global pharma industry’s growth. According to a ResearchAndMarkets report, the global pharmaceutical manufacturing market is expected to reach $813.31 billion in 2026, growing at a 12.3% CAGR of 12.3%.
